Dengzhan Xixin injection as an adjuvant treatment for angina pectoris: a systematic review and Meta-analysis of randomized controlled trials.
- Author:
Feng-jiao WANG
;
Yan-ming XIE
;
Xing LIAO
;
Min JIA
- Publication Type:Journal Article
- MeSH:
Adjuvants, Pharmaceutic;
Adult;
Aged;
Angina Pectoris;
drug therapy;
physiopathology;
Drugs, Chinese Herbal;
administration & dosage;
Electrocardiography;
Female;
Heart;
physiopathology;
Humans;
Injections;
Male;
Middle Aged;
Randomized Controlled Trials as Topic
- From:
China Journal of Chinese Materia Medica
2015;40(16):3298-3307
- CountryChina
- Language:Chinese
-
Abstract:
The paper is to systematically evaluate the efficacy and safety of Deng Zhan Xi Xin injection ( DZXXI) as an adjuvant treatment for patients with angina pectoris. The Cochrane Library, Medline, EMbase, CBM, CNKI, VIP, and Wan fang Data base were searched. Randomized controlled trials (RCTs) of DZXXI combined with western medicine routine treatment versus western medicine routine treatment alone for angina pectoris patients were all included. All trials were assessed according to the Cochrane Reviewer' s Handbook 5.1 for Systematic Reviews of Intervention and Meta analyses were performed by RevMan 5. 2 Software. A total of 30RCTs (3 086 patients including 1 572 patients of treatment group and 1 514 patients of control group) were included. Meta-analysis of treatment group compared with control group showed superior effect over reducing cardiovascular events ( OR = 0.33; 95% CI: [0.16, 0.67], P = 0.002, improving effective rate of DZXXI as adjuvant treatment for angina pectoris patients (OR = 3.97; 95% CI: [3.15, 5.02]; P < 0.000 010 and electrocardiogram curative effect (OR = 2.21; 95% CI; [1.83, 2.68]; P < 0.000 010. Funnel figure seemed that there was publication bias. The current limited evidence showed that when compared with the control group, treatment group was superior in improving patients with angina pectoris. But based on the limitations of the study, rigorous design with long follow up clinical trials are necessary for further evidence.
